2 papers
stat.AP2019
Mixture survival models methodology: an application to cancer immunotherapy assessment in clinical trials
Lizet Sanchez, Patricia Lorenzo-Luaces, Claudia Fonte +1
Progress in immunotherapy revolutionized the treatment landscape for advanced lung cancer, raising survival expectations beyond those that were historically anticipated with this d…
stat.AP2019
Identifying predictive biomarkers of CIMAvaxEGF success in advanced Lung Cancer Patients
Patricia Luaces, Lizet Sanchez, Danay Saavedra +5
Objectives: To identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non-Small Cell Lung Cancer Patients. Methods: Data from a clinical trial evaluating the effe…